Amalgamated Bank’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$211K Hold
4,880
﹤0.01% 1537
2025
Q1
$169K Buy
4,880
+17
+0.3% +$589 ﹤0.01% 1570
2024
Q4
$133K Hold
4,863
﹤0.01% 1656
2024
Q3
$124K Hold
4,863
﹤0.01% 1668
2024
Q2
$123K Buy
4,863
+962
+25% +$24.3K ﹤0.01% 1674
2024
Q1
$121K Sell
3,901
-10,527
-73% -$327K ﹤0.01% 1691
2023
Q4
$582K Sell
14,428
-1,347
-9% -$54.3K ﹤0.01% 1387
2023
Q3
$416K Buy
15,775
+576
+4% +$15.2K ﹤0.01% 1501
2023
Q2
$261K Buy
15,199
+1,901
+14% +$32.6K ﹤0.01% 1714
2023
Q1
$220K Sell
13,298
-2,178
-14% -$36K ﹤0.01% 1763
2022
Q4
$118K Hold
15,476
﹤0.01% 2073
2022
Q3
$154K Buy
15,476
+165
+1% +$1.64K ﹤0.01% 1949
2022
Q2
$139K Sell
15,311
-483
-3% -$4.39K ﹤0.01% 2036
2022
Q1
$160K Sell
15,794
-1,398
-8% -$14.2K ﹤0.01% 2025
2021
Q4
$287K Sell
17,192
-285
-2% -$4.76K ﹤0.01% 1846
2021
Q3
$819K Sell
17,477
-1,133
-6% -$53.1K 0.01% 1343
2021
Q2
$1.13M Buy
18,610
+5,217
+39% +$318K 0.01% 1231
2021
Q1
$825K Buy
13,393
+2,011
+18% +$124K 0.03% 688
2020
Q4
$809K Buy
11,382
+57
+0.5% +$4.05K 0.03% 684
2020
Q3
$425K Sell
11,325
-333
-3% -$12.5K 0.02% 927
2020
Q2
$380K Sell
11,658
-1,381
-11% -$45K 0.02% 981
2020
Q1
$378K Buy
+13,039
New +$378K 0.01% 1036